2017
DOI: 10.2215/cjn.07460716
|View full text |Cite
|
Sign up to set email alerts
|

Access to Kidney Transplantation among HIV-Infected Waitlist Candidates

Abstract: Our findings highlight the need for additional study to better understand disparities in access to kidney transplantation, particularly living donor kidney transplantation, among HIV+ kidney waitlist candidates.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
66
0
2

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 53 publications
(73 citation statements)
references
References 24 publications
(24 reference statements)
5
66
0
2
Order By: Relevance
“…26 Using the French national renal replacement therapy registry, and in a context of universal and free access to ART, we compared the access to the KT waiting list of PLHIV and matched HIV-uninfected patients who initiated dialysis between 2006 and 2010 and who were followed until December 2015. 26 Using the French national renal replacement therapy registry, and in a context of universal and free access to ART, we compared the access to the KT waiting list of PLHIV and matched HIV-uninfected patients who initiated dialysis between 2006 and 2010 and who were followed until December 2015.…”
Section: Introductionmentioning
confidence: 99%
“…26 Using the French national renal replacement therapy registry, and in a context of universal and free access to ART, we compared the access to the KT waiting list of PLHIV and matched HIV-uninfected patients who initiated dialysis between 2006 and 2010 and who were followed until December 2015. 26 Using the French national renal replacement therapy registry, and in a context of universal and free access to ART, we compared the access to the KT waiting list of PLHIV and matched HIV-uninfected patients who initiated dialysis between 2006 and 2010 and who were followed until December 2015.…”
Section: Introductionmentioning
confidence: 99%
“…While IMS data provides an opportunity to follow trends, it is not all encompassing, especially in certain special populations. In a 2017 study from the same authors, only 56% of wait‐listed patients had recorded pharmacy fills in the IMS database after the time they were listed . Additionally, it is unclear which pharmacies and health systems provide access to this database, as a prior report to the President of the United States noted that pharmacies within facilities were not accounted for in IMS data .…”
Section: Discussionmentioning
confidence: 99%
“…In a 2017 study from the same authors, only 56% of wait-listed patients had recorded pharmacy fills in the IMS database after the time they were listed. 21 Additionally, it is unclear which pharmacies and health systems provide access to this database, as a prior report to the President of the United States noted that pharmacies within facilities were not accounted for in IMS data. 22 This includes mail order and hospital-based specialty pharmacies, which for many large transplant centers, including our own, most patients use to fill all of their medications initially post-transplant.…”
Section: Post-transplant Fill Data For the Srtr Study Was Captured Thmentioning
confidence: 99%
“…Widespread adoption of potent antiretroviral therapy (ARV) has contributed to a decline in ESRD among whites with HIV infection, but rates of ESRD are still disproportionately higher among affected blacks. 143 However, kidney transplantation is associated with a survival benefit, compared with remaining on the waitlist (adjusted risk ratio [aRR], 0.21; 95% CI, 0.10 to 0.42; P <0.001), for HIV-positive patients, as has been observed for other high-risk patient groups. Of the 309 HIV-positive patients evaluated at a single transplant center from 2000 to 2007, only 20% achieved wait-listing compared with 73% of HIV-negative patients during the same time period.…”
Section: Human Immunodeficiency Virusmentioning
confidence: 92%